Dashboard
Manage Tickers

OMER


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

omeros-q3-adj-eps-034-beats-045-estimate
Omeros Q3 Adj. EPS $(0.34) Beats $(0.45) E...
11/13/2025 21:28:34

Omeros (NASDAQ:OMER) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.45) by 23....

earnings-scheduled-for-november-13-2025
Earnings Scheduled For November 13, 2025
11/13/2025 11:11:32

examining-the-future-omeross-earnings-outlook
Examining the Future: Omeros's Earnings Ou...
11/12/2025 15:02:37

4-biotech-stocks-lifting-off-as-momentum-builds
4 Biotech Stocks Lifting Off As Momentum B...
10/21/2025 15:49:39

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and...

gold-falls-1-slb-posts-better-than-expected-q3-earnings
Gold Falls 1%; SLB Posts Better-Than-Expec...
10/17/2025 16:17:56

d-boral-capital-maintains-buy-on-omeros-maintains-36-price-target
D. Boral Capital Maintains Buy on Omeros, ...
10/16/2025 19:22:01

D. Boral Capital analyst Jason Kolbert maintains Omeros (NASDAQ:OMER) with a Buy and maintains $36 price target.

omeros-published-study-in-blood-advances-shows-narsoplimab-significantly-improves-survival-in-high-risk-ta-tma-patients
Omeros Published Study In "Blood Advances"...
10/16/2025 12:39:07

Omeros Corporation (NASDAQ:OMER) today announced the publication of a peer-reviewed manuscript in Blood Advances, a journal of ...

satellogic-hewlett-packard-enterprise-bitfarms-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Satellogic, Hewlett Packard Enterprise, Bi...
10/16/2025 12:01:21

why-jb-hunt-transport-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why J.B. Hunt Transport Shares Are Trading...
10/16/2025 09:30:41

hims--hers-salesforce-omeros-united-airlines-and-sea-ltd-why-these-5-stocks-are-on-investors-radars-today
Hims & Hers, Salesforce, Omeros, United Ai...
10/16/2025 01:36:24

Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31.

omeros-stock-skyrockets-after-novo-nordisk-strikes-21b-rare-disease-drug-deal
Omeros Stock Skyrockets After Novo Nordisk...
10/15/2025 18:58:04

Omeros stock jumps 164% as Novo Nordisk acquires global rights to zaltenibart, with potential milestones reaching $2.1 billion ...

gold-gains-over-1-abbott-shares-fall-after-q3-results
Gold Gains Over 1%; Abbott Shares Fall Aft...
10/15/2025 18:20:16

needham-reiterates-hold-on-omerosto-hold
Needham Reiterates Hold on Omerosto Hold
10/15/2025 17:47:38

Needham analyst Serge Belanger reiterates Omeros (NASDAQ:OMER) from Hold to Hold.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 17:07:00

wbb-securities-reiterates-strong-buy-on-omeros-maintains-45-price-target
WBB Securities Reiterates Strong Buy on Om...
10/15/2025 16:11:14

WBB Securities analyst Steve Brozak reiterates Omeros (NASDAQ:OMER) with a Strong Buy and maintains $45 price target.

hc-wainwright--co-maintains-buy-on-omeros-raises-price-target-to-20
HC Wainwright & Co. Maintains Buy on Omero...
10/15/2025 16:05:25

HC Wainwright & Co. analyst Brandon Folkes maintains Omeros (NASDAQ:OMER) with a Buy and raises the price target from $9...

sp-500-gains-1-bank-of-america-posts-upbeat-earnings
S&P 500 Gains 1%; Bank of America Posts Up...
10/15/2025 14:17:51

d-boral-capital-maintains-buy-on-omeros-maintains-36-price-target
D. Boral Capital Maintains Buy on Omeros, ...
10/15/2025 13:40:01

D. Boral Capital analyst Jason Kolbert maintains Omeros (NASDAQ:OMER) with a Buy and maintains $36 price target.

Core News & Articles
Novo Nordisk Acquires Global Rights To Zal...
10/15/2025 12:34:16

Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk's Rar...

d-boral-capital-maintains-buy-on-omeros-maintains-36-price-target
D. Boral Capital Maintains Buy on Omeros, ...
09/03/2025 11:15:15

D. Boral Capital analyst Jason Kolbert maintains Omeros (NASDAQ:OMER) with a Buy and maintains $36 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION